Clinical validity of single-gene non-invasive prenatal testing for sickle cell disease and beta thalassemia
Erik R. Westin, David Tsao, Oguzhan Atay, Brian P. Landry, Patrick Peiyong Ye, Devon B. Chandler-Brown, Brian D. Alford, Jennifer M. Hoskovec, Akila Subramaniam, Kevin M. Pawlik, Spencer G. Kuper, Frederick D. Goldman, Tim M. Townes, Vivien Sheehan
This study validates a single-gene non-invasive prenatal test (NIPT) for sickle cell disease and beta thalassemia, showing 100% concordance with newborn screening in 79 pregnancies.
medRxiv · Sep 2, 2021 · PreprintGenetic & Genomic Medicine